Photocure ASA (OSL:PHO)

Norway flag Norway · Delayed Price · Currency is NOK
54.20
-0.20 (-0.37%)
Apr 16, 2025, 1:05 PM CET
-3.04%
Market Cap 1.44B
Revenue (ttm) 525.39M
Net Income (ttm) -3.34M
Shares Out 26.61M
EPS (ttm) -0.12
PE Ratio n/a
Forward PE 180.67
Dividend n/a
Ex-Dividend Date n/a
Volume 9,575
Average Volume 66,526
Open 50.60
Previous Close 54.40
Day's Range 53.40 - 54.40
52-Week Range 47.00 - 69.00
Beta 0.71
RSI 52.56
Earnings Date Apr 11, 2025

About Photocure ASA

Photocure ASA, together with its subsidiaries, engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products in the Nordic countries, Germany, France, Austria, the United Kingdom, the Benelux, Italy, rest of the Europe, Canada, and the United States. It operates through Commercial Franchise and Development Portfolio segments. The company offers Hexvix/Cysview for the detection and management of bladder cancer. It also develops Cevira for the treatment of human papilloma virus-induced cervical pre... [Read more]

Sector Healthcare
Founded 1993
Employees 102
Stock Exchange Oslo Børs
Ticker Symbol PHO
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.